Melo et al., 2014 - Google Patents
Antiperoxidative properties of oil mixes of high ratio Omega-9: Omega-6 and low ratio Omega-6: Omega-3 after molar extraction in ratsMelo et al., 2014
View HTML- Document ID
- 2021564631036368511
- Author
- Melo R
- Guimarães S
- Silva P
- Oriá R
- Melo J
- Vasconcelos P
- Publication year
- Publication venue
- Acta Cirúrgica Brasileira
External Links
Snippet
PURPOSE: To evaluate the antioxidant and antiperoxidative effects of oil mixes of high ratio Omega-9: Omega-6 and low ratio Omega-6: Omega-3 in the third day after tooth extraction in rats. METHODS: Thirty-two male Wistar rats (270-310g) were randomly distributed in two …
- 241000700159 Rattus 0 title abstract 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cruz-Jentoft et al. | Nutritional strategies for maintaining muscle mass and strength from middle age to later life: A narrative review | |
| Harris et al. | Omega-3 fatty acids and cardiovascular disease: new developments and applications | |
| Abdel Moneim et al. | Oral mucositis: melatonin gel an effective new treatment | |
| Klek et al. | Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)–a double-blind, randomised, multicentre study in adults | |
| Gura et al. | Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition | |
| Leong et al. | Heated palm oil causes rise in blood pressure and cardiac changes in heart muscle in experimental rats | |
| Cansev et al. | A specific multi-nutrient enriched diet enhances hippocampal cholinergic transmission in aged rats | |
| MX2013009007A (en) | High protein nutritional compositions and methods of making and using same. | |
| Melo et al. | Antiperoxidative properties of oil mixes of high ratio Omega-9: Omega-6 and low ratio Omega-6: Omega-3 after molar extraction in rats | |
| JP2010526873A (en) | Immune or hematological enhancement, inhibition of tumor formation or growth, and methods of treatment or prevention of cancer, cancer symptoms or cancer treatment symptoms | |
| JP2014510530A5 (en) | Nutritional compositions that increase arginine levels | |
| Ren et al. | Lipid emulsions in parenteral nutrition: current applications and future developments | |
| RU2018136872A (en) | COMPOSITIONS CONTAINING 15-OH EPA AND WAYS OF THEIR APPLICATION | |
| US20120321602A1 (en) | Omega-3 fatty acid nutriceutical composition and optimization method | |
| JP2014505702A5 (en) | ||
| CA2613792A1 (en) | Methods and compositions for the prevention and treatment of inflammatory disease | |
| RU2013146517A (en) | COMPOSITIONS AND METHODS SUITABLE FOR FACILITATION OF AGE DISEASES | |
| BR112020011411A2 (en) | food additive compositions | |
| AU2013264466A1 (en) | Improved complexes and compositions containing curcumin | |
| CN112839670A (en) | Ingestible formulations | |
| Levy et al. | Sar1b transgenic male mice are more susceptible to high-fat diet-induced obesity, insulin insensitivity and intestinal chylomicron overproduction | |
| MX2021014561A (en) | Methods and compositions for preventing or minimizing epithelial-mesenchymal transition. | |
| Arshad et al. | Cellular and plasma uptake of parenteral omega-3 rich lipid emulsion fatty acids in patients with advanced pancreatic cancer | |
| Da Porto et al. | Nutritional supplementation on wound healing in diabetic foot: What is known and what is new? | |
| Owens | Nutritional support to counteract muscle atrophy |